SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dwc who wrote (19036)4/14/1998 10:39:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
dwc, There is quite a bit of upcoming good news. Here's what BancAmerica/Robertson Stephens had to say in February:

UPCOMING EVENTS: Upcoming events for Ligand include: (1) FDA filing of topical Panretin for
KS expected in Q1:98; (2) initiate Phase II clinical trials of Targretin to treat breast cancer in 2H:98; (3)
file NDA for Targretin in CTCL in 1998; (4) file NDA for oral Panretin to treat KS in 1999; (5) select
oncology product from Eli Lilly as part of metabolic disease collaboration; (6) interim results from
Phase II clinical trials of oral Targretin to treat ovarian and prostate expected in early 1998; (7) results
from Phase II/II clinical trial of oral Targretin to treat CTCL in 1H:98; (8) results from Phase II studies
of oral Targretin for renal cell carcinoma, ovarian cancer, and prostate cancer expected in early 1998;
(9) results of Phase III clinical trial of oral Panretin to treat APL expected in 1H:99; (10) Ligand/AHP
expected to file an IND in the estrogen/progesterone area in 1998; (11) Ligand/Pfizer expected to file
droloxifene to treat breast cancer in 1998; (12) Ligand/Glaxo expected to select a novel cholesterol
clinical candidate in 1H:98; (13) Ligand/SmithKline expected to select a hemotopoietic factor clinical
candidate in 1998.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News